In this study, we identified PDZ protein NHERF1 as a novel GPER-binding partner in both HEK-293 and breast cancer cells by using GST pull-down, co-IP and confocal immunofluorescent assays (Figures 1–3). Here, GPER1 is linked to breast carcinoma.